Yuji Eso (Y Eso)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 26

Top Venues

Hepatology communications

Hepatology research : the official journal of the Japan Society of Hepatology

Cancers

Journal of gastroenterology and hepatology

京都大学 / Kyoto University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

京都大学 / Kyoto University Jun 24 2020

Japan

特定病院助教 / Program-Specific Assistant Professor, University Hospital :: 医学部附属病院 / Kyoto University Hospital

Kyoto University Graduate School of Medicine Nov 01 2019

Japan

Assistant professor :: Gastroenterology and Hepatology

Kyoto University Graduate School of Medicine Apr 01 2011 - Oct 31 2019

Japan

Medical staff :: Gastroenterology and Hepatology

Publications

Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Eriko Iguchi, Yuji Eso, Takahiro Shimizu, Ken Takahashi, Taiki Yamashita, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology communications 7 (3) (2023)
Ken Kumagai, Takahiro Shimizu, Atsushi Takai, Nobuyuki Kakiuchi, Yasuhide Takeuchi, Tomonori Hirano, Haruhiko Takeda, Aya Mizuguchi, Mari Teramura, Takahiko Ito, Eriko Iguchi, Mitsuhiro Nikaido, Yuji Eso, Ken Takahashi, Yoshihide Ueda, Shin'ichi Miyamoto, Kazutaka Obama, Seishi Ogawa, Hiroyuki Marusawa, Hiroshi Seno
Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field Cancerization. Cancer research 82 (9) (2022)
Natsumi Oe, Haruhiko Takeda, Yuji Eso, Atsushi Takai, Hiroyuki Marusawa
Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication. Pathogens (Basel, Switzerland) 11 (4) (2022)
Yuji Eso, Hironori Shimizu, Atsushi Takai, Ken Takahashi, Hiroshi Seno
Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: A single-center experience. Hepatology research : the official journal of the Japan Society of Hepatology 52 (6) (2022)
Haruhiko Takeda, Atsushi Takai, Yuji Eso, Ken Takahashi, Hiroyuki Marusawa, Hiroshi Seno
Genetic Landscape of Multistep Hepatocarcinogenesis. Cancers 14 (3) (2022)
Yuji Eso, Haruhiko Takeda, Kojiro Taura, Atsushi Takai, Ken Takahashi, Hiroshi Seno
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 28 (5) (2021)
Yuji Eso, Shigeharu Nakano, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Kojiro Taura, Hiroshi Seno
Mac-2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinoma. Journal of hepato-biliary-pancreatic sciences 28 (6) (2021)
Yuji Eso, Kojiro Taura, Hiroshi Seno
Does immune checkpoint inhibitor exhibit limited efficacy against non-viral hepatocellular carcinoma?: A review of clinical trials. Hepatology research : the official journal of the Japan Society of Hepatology (2021)
Yuji Eso, Hiroshi Seno
Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers. Therapeutic advances in gastroenterology 13 (2020)
Yuji Eso, Shigeharu Nakano, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Hiroshi Seno
Branched-chain amino acid to tyrosine ratio is an essential pre-treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinoma. Journal of hepato-biliary-pancreatic sciences 27 (12) (2020)
Haruhiko Takeda, Atsushi Takai, Ken Kumagai, Eriko Iguchi, Soichi Arasawa, Yuji Eso, Takahiro Shimizu, Yoshihide Ueda, Kojiro Taura, Shinji Uemoto, Ryuichi Kita, Hironori Haga, Hiroyuki Marusawa, Akihiro Fujimoto, Hiroshi Seno
Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution. The Journal of pathology 252 (4) (2020)
Yuji Eso
Microsatellite instability analysis using multiplex polymerase chain reaction with fluorescently labeled primers for amplification of five mononucleotide repeat markers. Hepatology research : the official journal of the Japan Society of Hepatology (2020)
Shigeharu Nakano, Yuji Eso, Hirokazu Okada, Atsushi Takai, Ken Takahashi, Hiroshi Seno
Recent Advances in Immunotherapy for Hepatocellular Carcinoma. Cancers 12 (4) (2020)
Yuji Eso, Tadayuki Kou, Hiroki Nagai, Young Hak Kim, Masashi Kanai, Shigemi Matsumoto, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Fumiyasu Nakamura, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Manabu Muto, Hiroshi Seno
Utility of ultrasound-guided liver tumor biopsy for next-generation sequencing-based clinical sequencing. Hepatology research : the official journal of the Japan Society of Hepatology 49 (5) (2019)
Yuji Eso, Shigeharu Nakano, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Fumiyasu Nakamura, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Kojiro Taura, Hiroshi Seno
Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma. Cancers 12 (1) (2019)
Yuji Eso, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Kojiro Taura, Hiroyuki Marusawa, Hiroshi Seno
Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 11 (3) (2019)
Yuji Eso, A Takai, S Arasawa, Y Ueda, H Seno
Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guérin disease. Journal of gastroenterology and hepatology 32 (9) (2019)
Yuji Eso, Atsushi Takai, Kojiro Taura, Ken Takahashi, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease. Journal of gastroenterology and hepatology (2018)
Yuji Eso, M Yoshioka, H Seno
Gastrointestinal: Lanthanum phosphate deposition in the gastroduodenal mucosa: An unusual cause of epigastric discomfort. Journal of gastroenterology and hepatology 33 (6) (2018)
Yuji Eso, Akihiro Furuta, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Ultrasound-guided microfoam sclerotherapy with polidocanol for symptomatic giant hepatic cyst: Initial experience. Hepatology research : the official journal of the Japan Society of Hepatology 48 (12) (2018)
Yuji Eso, Hiroyuki Marusawa
Novel approaches for molecular targeted therapy against hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 48 (8) (2018)

Yuji Eso.css-eqlu8i{font-size:small;padding-left:4px;} (Y Eso)

Publication Activity (10 Years)

Top Topics

Top Venues

Yuji Eso (Y Eso)